Dubai, UAE –  May 2025: Endocare, a leading metabolic health company dedicated to transforming lives by bridging innovative treatments with personalised care, has proudly announced the successful closing of its financing for its Middle East expansion. The milestone marks a significant step as the company progresses to scale its operations while simultaneously advancing its mission of delivering cutting-edge healthcare solutions across the Middle East.

RbetaQ Holding, a Germany-based family office boasting a strong track record of supporting innovative ventures in healthcare and technology, led the financing which saw Endocare’s ambitious growth plans expand into the UAE and Saudi Arabia.